ReviewTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

IL-22: a promising candidate to inhibit viral-induced liver disease progression and hepatocellular carcinoma.

Muhammad Saalim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.